January 19, 2017 4:38 AM ET

Pharmaceuticals

Company Overview of Altiris Therapeutics, Inc.

Executive Profile

Joseph Amprey III, M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 6 different industries.

See Board Relationships
----

Background

Dr. Joseph Amprey III, also known as Joe, M.D, Ph.D served as the Chief Business Officer of Zyngenia Inc. Dr. Amprey served as a Principal of MedImmune Ventures Inc. since 2006 and Senior Managing Director since 2008. Dr. Amprey joined MedImmune Ventures from Carrot Capital (CCHV) where he was responsible for deal sourcing and had operational roles within CCHV's portfolio companies. Dr. Amprey was responsible for deal sourcing and served operational roles within the ...

Corporate Headquarters

311 Ferst Drive, NW
Atlanta, Georgia 30332

United States

Phone: 404-537-4961
Fax: 404-537-4970

Board Members Memberships

Director

Education

PhD
Cornell University
MD
Cornell University
Bachelor's Degree
University of Pennsylvania
BA
University of Pennsylvania
Doctorate
Weill Cornell Medical College, New York
Bachelor's Degree
Weill Cornell Medical College, New York
MD
Weill Cornell Medical College, New York

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Altiris Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.